圣诺生物2025年上半年净利润同比增长308.29%

Core Viewpoint - Shengnuo Bio announced significant growth in revenue and net profit for the first half of 2025, indicating strong operational performance and potential for future investment opportunities [1] Financial Performance - The company achieved operating revenue of 338 million yuan, representing a year-on-year increase of 69.69% [1] - Net profit attributable to shareholders reached 88.96 million yuan, marking a substantial year-on-year growth of 308.29% [1] - The net profit after deducting non-recurring gains and losses was 89.48 million yuan, reflecting a remarkable year-on-year increase of 367.92% [1]